193 related articles for article (PubMed ID: 6120845)
1. Characterization of the beta-adrenergic inhibition of motility in cat colon strips.
Ek B; Lundgren B
Eur J Pharmacol; 1982 Jan; 77(1):25-31. PubMed ID: 6120845
[TBL] [Abstract][Full Text] [Related]
2. Beta-adrenergic control of motility in the rat colon. I. Evidence for functional separation of the beta 1- and beta 2-adrenoceptor-mediated inhibition of colon activity.
Ek BA; Bjellin LA; Lundgren BT
Gastroenterology; 1986 Feb; 90(2):400-7. PubMed ID: 2867001
[TBL] [Abstract][Full Text] [Related]
3. Studies on mechanisms for beta-adrenoceptor mediated inhibition of colon motility.
Ek B
Acta Physiol Scand Suppl; 1985; 546():1-39. PubMed ID: 2869641
[TBL] [Abstract][Full Text] [Related]
4. Beta adrenergic influence on esophageal and colonic motility in man.
Lyrenäs E
Scand J Gastroenterol Suppl; 1985; 116():1-48. PubMed ID: 2864739
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic receptor interaction with full and partial beta-adrenoceptor agonists in the rat colon strip.
Ek B
Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):140-5. PubMed ID: 2897085
[TBL] [Abstract][Full Text] [Related]
6. Effects of in vivo treatment with isoprenaline or prenalterol on beta-adrenoceptor mechanisms in the heart and soleus muscle of the cat.
Hedberg A; Mattsson H; Nerme V; Carlsson E
Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):251-8. PubMed ID: 6145101
[TBL] [Abstract][Full Text] [Related]
7. beta 1-Adrenoceptors mediating relaxation of the guinea-pig trachea: experiments with prenalterol, a beta 1-selective adrenoceptor agonist.
Johansson U; Waldeck B
J Pharm Pharmacol; 1981 Jun; 33(6):353-6. PubMed ID: 6115005
[TBL] [Abstract][Full Text] [Related]
8. Basic pharmacological properties of prenalterol.
Mattsson H; Hedberg A; Carlsson E
Acta Med Scand Suppl; 1982; 659():9-37. PubMed ID: 6127902
[No Abstract] [Full Text] [Related]
9. Beta 1- and beta 2-adrenoceptor-mediated secretion of amylase from incubated rat parotid gland.
Carlsöö B; Danielsson A; Henriksson R
Acta Physiol Scand; 1984 Mar; 120(3):429-35. PubMed ID: 6204505
[TBL] [Abstract][Full Text] [Related]
10. Prenalterol is an agonist at beta 2- as well as at beta 1-adrenoceptors.
Apperley GH; Drew GM; Sullivan AT
Eur J Pharmacol; 1982 Jul; 81(4):659-63. PubMed ID: 6126381
[TBL] [Abstract][Full Text] [Related]
11. Theoretical and practical problems with the assessment of intrinsic efficacy of agonists: efficacy of reputed beta-1 selective adrenoceptor agonists for beta-2 adrenoceptors.
Kenakin TP
J Pharmacol Exp Ther; 1982 Nov; 223(2):416-23. PubMed ID: 6127403
[TBL] [Abstract][Full Text] [Related]
12. Functional assessment of beta adrenoceptor subtypes in human colonic circular and longitudinal (taenia coli) smooth muscle.
Manara L; Croci T; Aureggi G; Guagnini F; Maffrand JP; Le Fur G; Mukenge S; Ferla G
Gut; 2000 Sep; 47(3):337-42. PubMed ID: 10940268
[TBL] [Abstract][Full Text] [Related]
13. beta 1-and beta 2-adrenoceptor stimulatory effects of prenalterol.
Mattsson H; Andersson T; Carlsson E; Hedberg A; Lundgren B; Olsson T
Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):302-8. PubMed ID: 6132344
[TBL] [Abstract][Full Text] [Related]
14. Beta 2-receptors in the rat anterior pituitary mediate adrenergic stimulation of prolactin release.
Baes M; Denef C
Life Sci; 1984 Apr; 34(15):1447-54. PubMed ID: 6143234
[TBL] [Abstract][Full Text] [Related]
15. Failure of beta-adrenergic stimulation to affect cholecystokinin-stimulated sigmoid motility in man.
Lyrenäs E; Abrahamsson H; Dotevall G
Scand J Gastroenterol; 1985 Dec; 20(10):1169-74. PubMed ID: 2869574
[TBL] [Abstract][Full Text] [Related]
16. The lack of a pronounced preference of prenalterol for the beta-l-adrenoceptor subtype.
Rohm N; Wagner J; Schümann HJ
Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(1):85-8. PubMed ID: 6113550
[TBL] [Abstract][Full Text] [Related]
17. Beta 1-adrenoceptor mediated salivary gland enlargement in the rat.
Ekström J; Malmberg L
Experientia; 1984 Aug; 40(8):862-3. PubMed ID: 6147266
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic sympathomimetic activity of the partial agonist prenalterol in relation to beta adrenoceptor interaction in various tissues, in vitro.
Mattsson H; Hedberg A; Carlsson E
J Pharmacol Exp Ther; 1983 Mar; 224(3):654-61. PubMed ID: 6131123
[TBL] [Abstract][Full Text] [Related]
19. Dose-related antipermeability effect of terbutaline and its inhibition by a selective beta 2-receptor blocking agent.
Svensjö E; Roempke K
Agents Actions; 1985 Mar; 16(1-2):19-20. PubMed ID: 2860793
[No Abstract] [Full Text] [Related]
20. Rectosigmoid motility response to beta-adrenoceptor stimulation in patients with the irritable bowel syndrome.
Lyrenäs E; Abrahamsson H; Dotevall G
Scand J Gastroenterol; 1985 Dec; 20(10):1163-8. PubMed ID: 2869573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]